HCM
TBIO

Highbridge Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Highbridge Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-166,640
Closed -$1.65M – 83
2019
Q3 		$1.65M Sell
166,640
-139,590
-46% -$1.32M 0.24% 44
2019
Q2 		$3.87M Buy
+306,230
New +$3.23M 0.26% 75

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Highbridge Capital Management's TBIO Position: Q4 2019 in Review

Highbridge Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q4 2019, closing a stake of 166,640 shares — an estimated $1.65M sold.

Highbridge Capital Management first reported a position in TBIO in Q2 2019 and held it in 2 quarters. The position peaked at $3.87M in Q2 2019. 77 funds tracked by Wall St. Rank hold TBIO as of Q4 2019.

  • Highbridge Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Highbridge Capital Management sold 166,640 Translate Bio, Inc. Common Stock shares in Q4 2019, an estimated $1.65M.
  • Highbridge Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • Highbridge Capital Management's Translate Bio, Inc. Common Stock position peaked at $3.87M in Q2 2019.
  • 77 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q4 2019.

Based on Highbridge Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.